ImageWare® Systems to Present at the 30th Annual ROTH Capital Partners Conference

SAN DIEGO, Feb. 26, 2018 -- ImageWare^® Systems, Inc. (OTCQB:IWSY), a leader in mobile and cloud-based, multi-modal biometric identity management solutions, today announced that the Company will present at the 30th Annual ROTH Capital Partners Conference on March 13, 2018 in Orange County, CA.

Jim Miller, Chairman and CEO, will present on Tuesday, March 13^th at 7:30am PT to discuss the Company’s technology and direct sales efforts as well as partner efforts of:

• Fujitsu – initiated sales efforts for GoVerifyID®
• IBM – validated GoVerifyID to integrate with IBM’s ISAM (Security Access Manager)
• CDW – initiated sales for GoVerifyID and IWS Cloud ID solutions

The presentation will be webcast live with slides (and available for replay) and can be accessed at: http://wsw.com/webcast/roth32/iwsy/.

About ROTH Capital Partners
ROTH Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, ROTH provides capital raising, M&A advisory, analytical research, trading, market-making services and corporate access. Headquartered in Newport Beach, CA, ROTH is privately held and employee owned, and maintains offices throughout the U.S. For more information on ROTH, please visit www.roth.com.

About ImageWare^®Systems, Inc.
ImageWare Systems, Inc. is a leading developer of mobile and cloud-based identity management solutions, providing patented biometric authentication solutions for the enterprise. Biometric technology uses unique physical characteristics to authenticate a person’s identity. The company delivers next-generation biometrics as an interactive and scalable cloud-based solution. ImageWare brings together cloud and mobile technology to offer multi-factor authentication for smartphone users, for the enterprise, and across industries. 

ImageWare’s products support multi-modal biometric authentication including, but not limited to, any individual use or combination of face, voice, fingerprint, iris, palm, and more. All the biometrics can be combined with or used as replacements for authentication and access control tools, including tokens, digital certificates, passwords, and PINS, to provide the ultimate level of assurance, accountability, and ease of use for corporate networks, web applications, mobile devices, and PC desktop environments.

ImageWare is headquartered in San Diego, California, with offices in Portland, Oregon, Ottawa, Ontario, and Mexico City, Mexico. To learn more about ImageWare, visit https://iwsinc.com/ and follow us on Twitter, LinkedIn, YouTube, and Facebook.

Forward Looking Statements
Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “project,” “predict,” “if,” “should” and “will” and similar expressions as they relate to ImageWare Systems, Inc. are intended to identify such forward-looking statements. ImageWare may from time to time update publicly announced projections, but it is not obligated to do so. Any projections of future results of operations should not be construed in any manner as a guarantee that such results will in fact occur. These projections are subject to change and could differ materially from final reported results. For a discussion of such risks and uncertainties, see “Risk Factors” in ImageWare’s Annual Report on Form 10-K for the fiscal year ended December 31, 2016 and its other reports filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.

Investor Relations Contact:                       
Harvey Bibicoff, CEO                                
Bibicoff + MacInnis, Inc.                                                    
818.379.8500    [email protected]